Scholarly Index
Allison B. Goldfine
Novartis (Switzerland); 26,244 total citations; 192 total publications; best world rank #86
Novartis (Switzerland)
26,244Total citations
192Total publications
70H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Bariatric Surgery and Outcomes | Lifetime | 86 | CH 1 | 98.63 |
| Diabetes Treatment and Management | Lifetime | 262 | CH 3 | 98.94 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 378 | CH 5 | 98.29 |
| Pharmacology and Obesity Treatment | Lifetime | 170 | CH 2 | 97.94 |
| Cardiovascular Disease and Adiposity | Lifetime | 597 | CH 4 | 97.09 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 693 | CH 4 | 97.78 |
| Metabolism, Diabetes, and Cancer | Lifetime | 945 | CH 22 | 96.89 |
| Cardiovascular Health and Disease Prevention | Lifetime | 871 | CH 11 | 96.43 |
| Diabetes Management and Research | Lifetime | 990 | CH 14 | 96.99 |
| Vitamin K Research Studies | Lifetime | 752 | CH 16 | 84.61 |